TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

Giles W Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.